Join the Overactive Bladder group to help and get support from people like you.
Overactive Bladder News (Page 2)
Related terms: Bladder Hyperactivity, Chronic overactivity of the bladder, Detrusor hyperreflexia, Detrusor instability, Incontinence, Urge, Irritable Bladder, Spasmodic Bladder, Unstable Bladder, Urge Incontinence, Urinary Frequency, OAB, Bladder Muscle Dysfunction - Overactive, bladder dysfunction
FDA Approves Gemtesa (vibegron) Tablets for the Treatment of Patients with Overactive Bladder (OAB)
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dec. 23, 2020-- Urovant Sciences (Nasdaq: UROV) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug...
FDA Approves Supplemental New Drug Application for Myrbetriq (mirabegron) for Use in Combination with Solifenacin Succinate for the Treatment of Overactive Bladder Symptoms
TOKYO, May 7, 2018 /PRNewswire/ – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food and Drug Administration (FDA) has approved...
FDA Approves Over-the-Counter Oxytrol for Women to treat Overactive Bladder
January, 25, 2013 – The U.S. Food and Drug Administration today approved Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women ages 18 years and older. Oxytrol...
FDA Approves Botox to Treat Overactive Bladder
January 18, 2013 – The U.S. Food and Drug Administration today expanded the approved use of Botox (onabotulinumtoxinA) to treat adults with overactive bladder who cannot use or do not adequately...
FDA Approves Myrbetriq for Overactive Bladder
June 28, 2012 - The U.S. Food and Drug Administration today approved Myrbetriq (mirabegron) to treat adults with overactive bladder, a condition in which the bladder muscle cannot be controlled,...
Anturol Approved by FDA for the Treatment of Overactive Bladder
PARSIPPANY, N.J. and EWING, N.J., Dec. 8, 2011 /PRNewswire/ – Watson Pharmaceuticals, Inc. and Antares Pharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved...